Viridian Therapeutics, Inc.\DE [VRDN] has reported $314.0 thousand in revenue for year ended Dec 31, 2023.
Also Read:
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $237.7 million.
Based in Waltham, Massachusetts, Viridian Therapeutics, Inc.\DE operates in the Services sector.